Eli Lilly Goes After Online Pharmacies for Allegedly Selling Unauthorized Versions of Diabetes Drug Mounjaro

In September, Eli Lilly filed lawsuits against eight companies in the U.S. that it claims are producing or selling compounded versions of its blockbuster diabetes drug Mounjaro.

Now, a month later, Lilly is going after 11 online pharmacies—including several overseas—that the company believes are importing, selling or distributing unauthorized versions of the treatment.

In a complaint filed with the U.S. International Trade Commission, Lilly has named three companies in China, three in Europe and five in the U.S. that claim their products contain tirzepatide, the active ingredient in Mounjaro. The companies are actually selling “low-grade” versions of the drug, Lilly said (PDF) in the filing.

Read the source article at Fierce Pharma